Lacut K - Search Results

1

Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.

Delluc A, Malécot JM, Kerspern H, Nowak E, Carre JL, Mottier D, Le Gal G, Lacut K. Delluc A, et al. Among authors: lacut k. Atherosclerosis. 2012 Jan;220(1):184-8. doi: 10.1016/j.atherosclerosis.2011.10.007. Epub 2011 Oct 14. Atherosclerosis. 2012. PMID: 22035572

2

Is APC resistance a risk factor for venous thromboembolism in patients over 70 years?

Oger E, Lacut K, Le Gal G, Van Dreden P, Bressollette L, Scarabin PY, Leroyer C, Mottier D. Oger E, et al. Among authors: lacut k. Thromb Haemost. 2002 Oct;88(4):587-91. Thromb Haemost. 2002. PMID: 12362228

3

High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients.

Oger E, Bressollette L, Nonent M, Lacut K, Guias B, Couturaud F, Leroyer C, Mottier D. Oger E, et al. Among authors: lacut k. Thromb Haemost. 2002 Oct;88(4):592-7. Thromb Haemost. 2002. PMID: 12362229

4

High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly.

Oger E, Lacut K, Van Dreden P, Bressollette L, Abgrall JF, Blouch MT, Scarabin PY, Mottier D. Oger E, et al. Among authors: lacut k. Haematologica. 2003 Apr;88(4):465-9. Haematologica. 2003. PMID: 12681975

5

Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial.

Oger E, Alhenc-Gelas M, Lacut K, Blouch MT, Roudaut N, Kerlan V, Collet M, Abgrall JF, Aiach M, Scarabin PY, Mottier D; SARAH Investigators. Oger E, et al. Among authors: lacut k. Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1671-6. doi: 10.1161/01.ATV.0000087141.05044.1F. Epub 2003 Jul 17. Arterioscler Thromb Vasc Biol. 2003. PMID: 12869355 Clinical Trial.

6

[Diagnosis of postoperative venous thromboembolism].

Moscoso MB, Mottier D, Nonent M, Couturaud F, Lacut K, Louis S, Leroyer C. Moscoso MB, et al. Among authors: lacut k. Presse Med. 2003 May 24;32(18):852-9. Presse Med. 2003. PMID: 12870391 Review. French.

7

Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein.

Lacut K, Oger E, Le Gal G, Blouch MT, Abgrall JF, Kerlan V, Scarabin PY, Mottier D; SARAH Investigators. Lacut K, et al. Thromb Haemost. 2003 Jul;90(1):124-31. Thromb Haemost. 2003. PMID: 12876635 Clinical Trial.

8

Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.

Lacut K, Oger E, Abalain JH, Moineau MP, Mottier D; SARAH Investigators. Lacut K, et al. Atherosclerosis. 2004 May;174(1):173-80. doi: 10.1016/j.atherosclerosis.2004.01.021. Atherosclerosis. 2004. PMID: 15135267 Clinical Trial.

9

Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study.

Lacut K, Oger E, Le Gal G, Couturaud F, Louis S, Leroyer C, Mottier D. Lacut K, et al. Fundam Clin Pharmacol. 2004 Aug;18(4):477-82. doi: 10.1111/j.1472-8206.2004.00252.x. Fundam Clin Pharmacol. 2004. PMID: 15312155

10

Assessment of the risk and prophylactic treatment of venous thromboembolism in the elderly.

Couturaud F, Lacut K, Leroyer C, Mottier D. Couturaud F, et al. Among authors: lacut k. Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):362-5. doi: 10.1159/000083830. Pathophysiol Haemost Thromb. 2003. PMID: 15692245 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters